Mansfield Bio-Incubator, 241 Francis Ave, Mansfield, MA 02048, USA Mansfield, MA, MA, 02048 United StatesProtavio is a leading multiplex proteomics company with over 20 years of experience. Harnessing the power of multi-platform proteomics, we combine the benefits of state-of-the-art technologies, including Olink & Luminex, to offer novel products and services for biomarker discovery, development and validation. Our GMP, ISO13485 and ISO9001 compliant quality management systems enable us to move beyond traditional CRO offerings and support our clients all the way from biomarker discovery to commercialization. Protavio has a proven track record in developing and commercializing assays under IVDR and ISO13485 standards, which have been successfully validated and are being used either as Laboratory Developed Tests (LDT) in CLIA labs or IVD kits. Finally, Protavio’s manufacturing facility currently produces over 1 million tests annually under cGMP conditions. SOLUTIONS Protavio offers cutting-edge proteomic analysis and assay development services, utilizing advanced platforms like Olink Explore and Luminex™ to cater to diverse research and clinical needs. Our services include: High-Plex Protein Analysis: Utilizing the Olink Explore platform, we provide comprehensive protein measurement capabilities, with options ranging from focused studies analyzing 384 proteins to large-scale investigations measuring up to 5700 targets from as little as 2ul of sample. Our tailored solutions, including Explore Individual 384x Target Kits, Explore 3k, and Explore HT, are designed to meet various research requirements and sample throughputs, offering precision, breadth, and high-throughput options. Mid-Plex Protein Analysis: Offering cost-effective and fast turnaround analysis for up to 100 proteins, our Mid-Plex solutions are powered by Luminex™ technology. Researchers can rely on validated panels or choose from over 1300 pre-made panels for robust protein landscape understanding and important biological mechanism validation. C-Plex Custom Assay Development: With our customizable C-Plex service, we develop protein assays tailored to your specific needs using Luminex™ technology. Our process is ISO13485 compliant and adheres to regulations for in-vitro diagnostic assays development, ensuring high-quality, reliable assays for your lab or as part of our mid-plex analysis service. GMP Production: We assist in translating biomarker research into clinical products, including RUO, IVD, and LDT assays. Our GMP production service encompasses design, development, production, and commercialization, adhering to IVDR, ISO13485 standards, and GMP to ensure the quality, safety, and efficacy of diagnostic products. This regulatory-centered approach enhances the commercial viability of your discoveries and contributes to healthcare improvements. FACILITIES Protavio has a global presence with offices in Cambridge, UK and sample storage facilities in MA, USA. Our headquarters & Lab/production facilities are housed in Demokritos Scientific Park Lefkippos, Athens, Greece. These state-of-the-art facilities are designed to meet the rigorous demands of proteomic analysis and production. With dedicated spaces for high-plex and mid-plex analyses, custom assay development, and IVD/GMP-compliant manufacturing, we have created environments that are as advanced as the science we conduct within them. Our labs are outfitted with the latest in Olink, Luminex and automation technology, ensuring that every sample is processed to deliver high-quality and actionable results.

20 Station Road Cambridge Cambridge, Cambridgeshire, CB1 2JD United KingdomProtavio is a leading multiplex proteomics company with over 20 years of experience. Harnessing the power of multi-platform proteomics, we combine the benefits of state-of-the-art technologies, including Olink & Luminex, to offer novel products and services for biomarker discovery, development and validation. Our GMP, ISO13485 and ISO9001 compliant quality management systems enable us to move beyond traditional CRO offerings and support our clients all the way from biomarker discovery to commercialization. Protavio has a proven track record in developing and commercializing assays under IVDR and ISO13485 standards, which have been successfully validated and are being used either as Laboratory Developed Tests (LDT) in CLIA labs or IVD kits. Finally, Protavio’s manufacturing facility currently produces over 1 million tests annually under cGMP conditions. SOLUTIONS Protavio offers cutting-edge proteomic analysis and assay development services, utilizing advanced platforms like Olink Explore and Luminex™ to cater to diverse research and clinical needs. Our services include: High-Plex Protein Analysis: Utilizing the Olink Explore platform, we provide comprehensive protein measurement capabilities, with options ranging from focused studies analyzing 384 proteins to large-scale investigations measuring up to 5700 targets from as little as 2ul of sample. Our tailored solutions, including Explore Individual 384x Target Kits, Explore 3k, and Explore HT, are designed to meet various research requirements and sample throughputs, offering precision, breadth, and high-throughput options. Mid-Plex Protein Analysis: Offering cost-effective and fast turnaround analysis for up to 100 proteins, our Mid-Plex solutions are powered by Luminex™ technology. Researchers can rely on validated panels or choose from over 1300 pre-made panels for robust protein landscape understanding and important biological mechanism validation. C-Plex Custom Assay Development: With our customizable C-Plex service, we develop protein assays tailored to your specific needs using Luminex™ technology. Our process is ISO13485 compliant and adheres to regulations for in-vitro diagnostic assays development, ensuring high-quality, reliable assays for your lab or as part of our mid-plex analysis service. GMP Production: We assist in translating biomarker research into clinical products, including RUO, IVD, and LDT assays. Our GMP production service encompasses design, development, production, and commercialization, adhering to IVDR, ISO13485 standards, and GMP to ensure the quality, safety, and efficacy of diagnostic products. This regulatory-centered approach enhances the commercial viability of your discoveries and contributes to healthcare improvements. FACILITIES Protavio has a global presence with offices in Cambridge, UK and sample storage facilities in MA, USA. Our headquarters & Lab/production facilities are housed in Demokritos Scientific Park Lefkippos, Athens, Greece. These state-of-the-art facilities are designed to meet the rigorous demands of proteomic analysis and production. With dedicated spaces for high-plex and mid-plex analyses, custom assay development, and IVD/GMP-compliant manufacturing, we have created environments that are as advanced as the science we conduct within them. Our labs are outfitted with the latest in Olink, Luminex and automation technology, ensuring that every sample is processed to deliver high-quality and actionable results.

The Bradfield Centre 184 Cambridge Science Park Cambridge, Cambridgeshire, CB4 0GA United KingdomProtavio is a leading multiplex proteomics company with over 20 years of experience. Harnessing the power of multi-platform proteomics, we combine the benefits of state-of-the-art technologies, including Olink & Luminex, to offer novel products and services for biomarker discovery, development and validation. Our GMP, ISO13485 and ISO9001 compliant quality management systems enable us to move beyond traditional CRO offerings and support our clients all the way from biomarker discovery to commercialization. Protavio has a proven track record in developing and commercializing assays under IVDR and ISO13485 standards, which have been successfully validated and are being used either as Laboratory Developed Tests (LDT) in CLIA labs or IVD kits. Finally, Protavio’s manufacturing facility currently produces over 1 million tests annually under cGMP conditions. SOLUTIONS Protavio offers cutting-edge proteomic analysis and assay development services, utilizing advanced platforms like Olink Explore and Luminex™ to cater to diverse research and clinical needs. Our services include: High-Plex Protein Analysis: Utilizing the Olink Explore platform, we provide comprehensive protein measurement capabilities, with options ranging from focused studies analyzing 384 proteins to large-scale investigations measuring up to 5700 targets from as little as 2ul of sample. Our tailored solutions, including Explore Individual 384x Target Kits, Explore 3k, and Explore HT, are designed to meet various research requirements and sample throughputs, offering precision, breadth, and high-throughput options. Mid-Plex Protein Analysis: Offering cost-effective and fast turnaround analysis for up to 100 proteins, our Mid-Plex solutions are powered by Luminex™ technology. Researchers can rely on validated panels or choose from over 1300 pre-made panels for robust protein landscape understanding and important biological mechanism validation. C-Plex Custom Assay Development: With our customizable C-Plex service, we develop protein assays tailored to your specific needs using Luminex™ technology. Our process is ISO13485 compliant and adheres to regulations for in-vitro diagnostic assays development, ensuring high-quality, reliable assays for your lab or as part of our mid-plex analysis service. GMP Production: We assist in translating biomarker research into clinical products, including RUO, IVD, and LDT assays. Our GMP production service encompasses design, development, production, and commercialization, adhering to IVDR, ISO13485 standards, and GMP to ensure the quality, safety, and efficacy of diagnostic products. This regulatory-centered approach enhances the commercial viability of your discoveries and contributes to healthcare improvements. FACILITIES Protavio has a global presence with offices in Cambridge, UK and sample storage facilities in MA, USA. Our headquarters & Lab/production facilities are housed in Demokritos Scientific Park Lefkippos, Athens, Greece. These state-of-the-art facilities are designed to meet the rigorous demands of proteomic analysis and production. With dedicated spaces for high-plex and mid-plex analyses, custom assay development, and IVD/GMP-compliant manufacturing, we have created environments that are as advanced as the science we conduct within them. Our labs are outfitted with the latest in Olink, Luminex and automation technology, ensuring that every sample is processed to deliver high-quality and actionable results.

Patriarchou Grigoriou & Neapoleos Demokritos Science Part - ProtATonce, Building27 Agia Paraskevi, Outside U.S., 15343 GreeceProtavio is a leading multiplex proteomics company with over 20 years of experience. Harnessing the power of multi-platform proteomics, we combine the benefits of state-of-the-art technologies, including Olink & Luminex, to offer novel products and services for biomarker discovery, development and validation. Our GMP, ISO13485 and ISO9001 compliant quality management systems enable us to move beyond traditional CRO offerings and support our clients all the way from biomarker discovery to commercialization. Protavio has a proven track record in developing and commercializing assays under IVDR and ISO13485 standards, which have been successfully validated and are being used either as Laboratory Developed Tests (LDT) in CLIA labs or IVD kits. Finally, Protavio’s manufacturing facility currently produces over 1 million tests annually under cGMP conditions. SOLUTIONS Protavio offers cutting-edge proteomic analysis and assay development services, utilizing advanced platforms like Olink Explore and Luminex™ to cater to diverse research and clinical needs. Our services include: High-Plex Protein Analysis: Utilizing the Olink Explore platform, we provide comprehensive protein measurement capabilities, with options ranging from focused studies analyzing 384 proteins to large-scale investigations measuring up to 5700 targets from as little as 2ul of sample. Our tailored solutions, including Explore Individual 384x Target Kits, Explore 3k, and Explore HT, are designed to meet various research requirements and sample throughputs, offering precision, breadth, and high-throughput options. Mid-Plex Protein Analysis: Offering cost-effective and fast turnaround analysis for up to 100 proteins, our Mid-Plex solutions are powered by Luminex™ technology. Researchers can rely on validated panels or choose from over 1300 pre-made panels for robust protein landscape understanding and important biological mechanism validation. C-Plex Custom Assay Development: With our customizable C-Plex service, we develop protein assays tailored to your specific needs using Luminex™ technology. Our process is ISO13485 compliant and adheres to regulations for in-vitro diagnostic assays development, ensuring high-quality, reliable assays for your lab or as part of our mid-plex analysis service. GMP Production: We assist in translating biomarker research into clinical products, including RUO, IVD, and LDT assays. Our GMP production service encompasses design, development, production, and commercialization, adhering to IVDR, ISO13485 standards, and GMP to ensure the quality, safety, and efficacy of diagnostic products. This regulatory-centered approach enhances the commercial viability of your discoveries and contributes to healthcare improvements. FACILITIES Protavio has a global presence with offices in Cambridge, UK and sample storage facilities in MA, USA. Our headquarters & Lab/production facilities are housed in Demokritos Scientific Park Lefkippos, Athens, Greece. These state-of-the-art facilities are designed to meet the rigorous demands of proteomic analysis and production. With dedicated spaces for high-plex and mid-plex analyses, custom assay development, and IVD/GMP-compliant manufacturing, we have created environments that are as advanced as the science we conduct within them. Our labs are outfitted with the latest in Olink, Luminex and automation technology, ensuring that every sample is processed to deliver high-quality and actionable results.

Patriarchou Grigoriou & Neapoleos 27 Demokritos Technology Park, Building 27 Agia Paraskevi, Attiki, 15341 GreeceProtavio is a leading multiplex proteomics company with over 20 years of experience. Harnessing the power of multi-platform proteomics, we combine the benefits of state-of-the-art technologies, including Olink & Luminex, to offer novel products and services for biomarker discovery, development and validation. Our GMP, ISO13485 and ISO9001 compliant quality management systems enable us to move beyond traditional CRO offerings and support our clients all the way from biomarker discovery to commercialization. Protavio has a proven track record in developing and commercializing assays under IVDR and ISO13485 standards, which have been successfully validated and are being used either as Laboratory Developed Tests (LDT) in CLIA labs or IVD kits. Finally, Protavio’s manufacturing facility currently produces over 1 million tests annually under cGMP conditions. SOLUTIONS Protavio offers cutting-edge proteomic analysis and assay development services, utilizing advanced platforms like Olink Explore and Luminex™ to cater to diverse research and clinical needs. Our services include: High-Plex Protein Analysis: Utilizing the Olink Explore platform, we provide comprehensive protein measurement capabilities, with options ranging from focused studies analyzing 384 proteins to large-scale investigations measuring up to 5700 targets from as little as 2ul of sample. Our tailored solutions, including Explore Individual 384x Target Kits, Explore 3k, and Explore HT, are designed to meet various research requirements and sample throughputs, offering precision, breadth, and high-throughput options. Mid-Plex Protein Analysis: Offering cost-effective and fast turnaround analysis for up to 100 proteins, our Mid-Plex solutions are powered by Luminex™ technology. Researchers can rely on validated panels or choose from over 1300 pre-made panels for robust protein landscape understanding and important biological mechanism validation. C-Plex Custom Assay Development: With our customizable C-Plex service, we develop protein assays tailored to your specific needs using Luminex™ technology. Our process is ISO13485 compliant and adheres to regulations for in-vitro diagnostic assays development, ensuring high-quality, reliable assays for your lab or as part of our mid-plex analysis service. GMP Production: We assist in translating biomarker research into clinical products, including RUO, IVD, and LDT assays. Our GMP production service encompasses design, development, production, and commercialization, adhering to IVDR, ISO13485 standards, and GMP to ensure the quality, safety, and efficacy of diagnostic products. This regulatory-centered approach enhances the commercial viability of your discoveries and contributes to healthcare improvements. FACILITIES Protavio has a global presence with offices in Cambridge, UK and sample storage facilities in MA, USA. Our headquarters & Lab/production facilities are housed in Demokritos Scientific Park Lefkippos, Athens, Greece. These state-of-the-art facilities are designed to meet the rigorous demands of proteomic analysis and production. With dedicated spaces for high-plex and mid-plex analyses, custom assay development, and IVD/GMP-compliant manufacturing, we have created environments that are as advanced as the science we conduct within them. Our labs are outfitted with the latest in Olink, Luminex and automation technology, ensuring that every sample is processed to deliver high-quality and actionable results.